Targeted Medical Pharma, Inc. (TRGM)

Other OTC - Other OTC Delayed Price. Currency in USD
0.020.00 (0.00%)
At close: 9:30 AM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.02
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52wk Range
1y Target EstN/A
Market Cap724.46k
P/E Ratio (ttm)-0.21
Avg Vol (3m)657
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire5 months ago

    Targeted Medical Pharma Combats the Epidemic of Pain with Release of THERALEVE™

    Targeted Medical Pharma, Inc. in conjunction with Amino Nutritionals LLC, today announced the consumer release of THERALEVE™ a patented amino acid based formula designed by pain management physicians to help the 100 million chronic pain sufferers in the United States, fight pain and inflammation without the dangerous side effects commonly associated with NSAIDs and opioids.

  • Business Wire7 months ago

    Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China

    Targeted Medical Pharma , today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes in distributing healthcare products throughout China.

  • Business Wire9 months ago

    Targeted Medical Pharma Breaks Ground in the Consumer Goods Market

    Targeted Medical Pharma, Inc. , announced the establishment of a new subsidiary, Amino Nutritionals LLC, that will specialize in the development and marketing of THERALEVE™, a proprietary consumer product for chronic pain sufferers to be sold in the United States and abroad.